Warren Lucinda 4
4 · Cue Biopharma, Inc. · Filed Sep 5, 2024
Insider Transaction Report
Form 4
Warren Lucinda
CHIEF BUSINESS OFFICER
Transactions
- Award
Stock Option (right to buy)
2024-09-03+350,000→ 350,000 totalExercise: $0.66Exp: 2034-09-02→ Common Stock (350,000 underlying)
Footnotes (1)
- [F1]This stock option becomes exercisable in four equal semi-annual installments beginning on March 3, 2025.